Researchers develop global hepatitis C recommendations for injection-drug users

According to data from the Centers for Disease Control and Prevention, around 12,000 people die every year from HCV-related liver disease. A researcher from Miriam Hospital has teamed up with an international panel of colleagues to discuss new strategies for improved management, assessment and treatment for hepatitis c infection among individuals who inject drugs. Dr. Lynn E. Tyler, an HIV specialist focusing on HIV and viral hepatitis co-infection at Miriam Hospital in Rhode Island, was the only American physician invited to join the international panel of experts who are the first to issue these kinds of recommendations. The recommendations developed by the panel were published July 24 in the journal Clinical Infectious Diseases, a few days prior to World Hepatitis Day on July 28. These new recommendations are part of a supplement titled Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward, which was a...